---
figid: PMC7346249__fimmu-11-01184-g0002
figlink: pmc/articles/PMC7346249/figure/F2/
number: Figure 2
caption: Schematic illustration of androgens/AR interaction, intracellular pathway,
  and molecular targets of androgen deprivation therapies (ADT). One important group
  of ADT drugs are the LHRH analogs. They reduce the release of LH, which promotes
  TST production by the testis. The other important groups are the anti-androgens,
  either involved in blocking androgens at the synthesis level or involved in interfering
  with androgen/AR binding (AR blockers). LH, luteinizing hormone; LHRH, LH releasing
  hormone; DHEA, dehydroepiandrosterone; AD, androstenedione; TST, testosterone; DHT,
  dihydrotestosterone; A, androgens; AR, androgen receptor.
pmcid: PMC7346249
papertitle: 'Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity
  and Cancer.'
reftext: Isabel Ben-Batalla, et al. Front Immunol. 2020;11:1184.
pmc_ranked_result_index: '18612'
pathway_score: 0.8718408
filename: fimmu-11-01184-g0002.jpg
figtitle: Androgens/AR interaction, intracellular pathway, and molecular targets of
  androgen deprivation therapies (ADT)
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7346249__fimmu-11-01184-g0002.html
  '@type': Dataset
  description: Schematic illustration of androgens/AR interaction, intracellular pathway,
    and molecular targets of androgen deprivation therapies (ADT). One important group
    of ADT drugs are the LHRH analogs. They reduce the release of LH, which promotes
    TST production by the testis. The other important groups are the anti-androgens,
    either involved in blocking androgens at the synthesis level or involved in interfering
    with androgen/AR binding (AR blockers). LH, luteinizing hormone; LHRH, LH releasing
    hormone; DHEA, dehydroepiandrosterone; AD, androstenedione; TST, testosterone;
    DHT, dihydrotestosterone; A, androgens; AR, androgen receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNRH1
  - CGA
  - LHB
  - TST
  - AR
  - Leuprorelin
  - Triptorelin
  - Dutasteride
  - Cyproterone
  - Nilutamide
  - Cholesterol Abiraterone
  - Bicalutamide
  - Enzalutamide
  - Apalutamide
  - Pregnolenone
  - DHEA
  - Darolutamide
  - Progesterone
  - Abiraterone
  - Prostate cancer
genes:
- word: LHRH
  symbol: LHRH
  source: hgnc_prev_symbol
  hgnc_symbol: GNRH1
  entrez: '2796'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: CGA
  entrez: '1081'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: LHB
  entrez: '3972'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: TST
  symbol: TST
  source: hgnc_symbol
  hgnc_symbol: TST
  entrez: '7263'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
chemicals:
- word: Leuprorelin
  source: MESH
  identifier: D016729
- word: Triptorelin
  source: MESH
  identifier: D017329
- word: Dutasteride
  source: MESH
  identifier: C108373
- word: Cyproterone
  source: MESH
  identifier: D003534
- word: Nilutamide
  source: MESH
  identifier: C021277
- word: Cholesterol Abiraterone
  source: MESH
  identifier: C089740
- word: Bicalutamide
  source: MESH
  identifier: C053541
- word: Enzalutamide
  source: MESH
  identifier: C540278
- word: Apalutamide
  source: ''
  identifier: ''
- word: Pregnolenone
  source: ''
  identifier: ''
- word: DHEA
  source: MESH
  identifier: D003687
- word: Darolutamide
  source: ''
  identifier: ''
- word: Progesterone
  source: MESH
  identifier: D011374
- word: Abiraterone
  source: MESH
  identifier: C089740
diseases:
- word: Prostate cancer
  source: MESH
  identifier: D011471
---
